Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 30;32(8):803-831.
doi: 10.1515/revneuro-2020-0134. Print 2021 Dec 20.

Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders

Affiliations
Free article
Review

Endocannabinoid system in the neurodevelopment of GABAergic interneurons: implications for neurological and psychiatric disorders

Chang-Geng Song et al. Rev Neurosci. .
Free article

Abstract

In mature mammalian brains, the endocannabinoid system (ECS) plays an important role in the regulation of synaptic plasticity and the functioning of neural networks. Besides, the ECS also contributes to the neurodevelopment of the central nervous system. Due to the increase in the medical and recreational use of cannabis, it is inevitable and essential to elaborate the roles of the ECS on neurodevelopment. GABAergic interneurons represent a group of inhibitory neurons that are vital in controlling neural network activity. However, the role of the ECS in the neurodevelopment of GABAergic interneurons remains to be fully elucidated. In this review, we provide a brief introduction of the ECS and interneuron diversity. We focus on the process of interneuron development and the role of ECS in the modulation of interneuron development, from the expansion of the neural stem/progenitor cells to the migration, specification and maturation of interneurons. We further discuss the potential implications of the ECS and interneurons in the pathogenesis of neurological and psychiatric disorders, including epilepsy, schizophrenia, major depressive disorder and autism spectrum disorder.

Keywords: GABAergic interneuron; autism spectrum disorder; endocannabinoid system; epilepsy; major depressive disorder; neurological disorders; schizophrenia.

PubMed Disclaimer

References

    1. Abraira, V.E., Kuehn, E.D., Chirila, A.M., Springel, M.W., Toliver, A.A., Zimmerman, A.L., Orefice, L.L., Boyle, K.A., Bai, L., Song, B.J., et al.. (2017). The cellular and synaptic architecture of the mechanosensory dorsal horn. Cell 168: 295–310.e219, https://doi.org/10.1016/j.cell.2016.12.010.
    1. Adorjan, I., Ahmed, B., Feher, V., Torso, M., Krug, K., Esiri, M., Chance, S.A., and Szele, F.G. (2017). Calretinin interneuron density in the caudate nucleus is lower in autism spectrum disorder. Brain 140: 2028–2040, https://doi.org/10.1093/brain/awx131.
    1. Aguado, T., Monory, K., Palazuelos, J., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzman, M., et al.. (2005). The endocannabinoid system drives neural progenitor proliferation. FASEB J. 19: 1704–1706, https://doi.org/10.1096/fj.05-3995fje.
    1. Aguado, T., Palazuelos, J., Monory, K., Stella, N., Cravatt, B., Lutz, B., Marsicano, G., Kokaia, Z., Guzmán, M., and Galve-Roperh, I. (2006). The endocannabinoid system promotes astroglial differentiation by acting on neural progenitor cells. J. Neurosci. 26: 1551–1561, https://doi.org/10.1523/jneurosci.3101-05.2006.
    1. Akbarian, S., Kim, J.J., Potkin, S.G., Hagman, J.O., Tafazzoli, A., Bunney, W.E.Jr., and Jones, E.G. (1995). Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch. Gen. Psychiatry 52: 258–266, https://doi.org/10.1001/archpsyc.1995.03950160008002.

Publication types

Substances

LinkOut - more resources